vimarsana.com

- Appoints Nancy J. Wysenski as New Lead Independent Director - - David W. Anstice AO and Wendy L. Dixon, Ph.D. to Retire From Board - - Files Preliminary Proxy Statement and Highlights

Related Keywords

Harvard University ,Massachusetts ,United States ,Boston ,Athlone ,Westmeath ,Ireland ,Waltham ,Ohio ,Cambridge ,Cambridgeshire ,United Kingdom ,Dublin ,Alex Denner ,Katie Joyce ,Emily Peterson Alva ,Davida Daglio ,Nancyj Wysenski ,Catot Laurencin ,Brianp Mckeon ,Christopher Wright ,Wendyl Dixon ,Vrije Universiteit ,Sandy Coombs ,Christopheri Wright ,Ironwood Pharmaceuticals Inc ,Global Medicines Development ,Corporate Governance Committee Of The Board ,Nasdaq ,Vertex Pharmaceuticals Incorporated ,Axcella Health Inc ,Professor Of Neurology At Harvard Medical School ,Cyclerion Therapeutics Inc ,Alkermes ,Corporate Governance Committee ,Wendy ,Harvard Medical School ,Aavantibio Inc ,Exchange Commission ,Biochemical Sciences ,New Lead Independent Director ,Retire From Board ,Preliminary Proxy Statement ,Highlights Shareholder Engagement Efforts ,Annual General Meeting ,Annual Meeting ,Investor Relations ,New Independent Director ,With Significant Neuroscience Expertise ,Chief Medical Officer ,Cyclerion Therapeutics ,Ironwood Pharmaceuticals ,Associate Professor ,Harvard Medical ,Alkerme Board ,Richard Pops ,Chief Executive Officer ,Longer Serving Directors ,Board Refreshment ,Lead Independent Director ,Peterson Alva ,Sarissa Capital Management ,Chief Investment Officer ,Sarissa Capital ,Senior Vice President ,Chief Development Officer ,Axcella Health ,Scientific Advisor ,Magna Cum Laude ,Clinical Investigation ,Private Securities Litigation Reform Act ,Annual Report ,Additional Information ,Information Regarding Participants ,Current Reports ,Initial Statements ,Beneficial Ownership ,Vertex Pharmaceuticals ,Nnounces ,Ontinued ,Board ,Efreshment ,Ncluding ,Appointment ,Christopher ,Right ,Directors ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.